Intravenously administered high dose ascorbic acid (HDIVC) as used in cases of patients with cancer and chronic infection has considerable mythology surrounding it. The purpose of this review is not to exhaustively recap the data regarding this therapy but rather to address basic issues of safety, pharmacology and outcomes of ongoing research.
I have been involved in the use of HDIVC for over twenty years, and have found it to be one of the most versatile and clinically useful agents in cancer and chronic illness I have used. It is not a panacea, but it also is not a placebo.
Intravenous Vitamin C in Cancer and Chronic infections-02-2016
